The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.25
Bid: 7.00
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.50 (7.143%)
Open: 7.25
High: 7.25
Low: 7.25
Prev. Close: 7.25
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

25 Apr 2022 13:00

RNS Number : 2350J
Belluscura PLC
25 April 2022
 

 25 April 2022 

Belluscura plc

("BELL" or the "Company")

Result of AGM

Belluscura plc (AIM: BELL) announces that at the Annual General Meeting ("AGM") held earlier today all the resolutions put to the meeting were duly approved by shareholders: 

Resolution (*indicates special resolution)

Votes for

% of shares voted

Votes against

% of shares voted

Resolution 1: To receive and adopt the report of the directors and the financial statements for the period ended 31 December 2021.

32,658,693

99.9%

4,000

0.01%

Resolution 2: To re-elect Mr Adam Reynolds as a director of the Company.

32,658,693

99.9%

4,000

0.01%

Resolution 3. To re-elect Mr Ric Piper as a director of the Company.

32,658,693

99.9%

4,000

0.01%

Resolution 4: To re-appoint Jeffreys Henry Audit Limited as auditors.

 

32,658,693

99.9%

4,000

0.01%

Resolution 5: To authorise the directors to determine the remuneration of the auditors.

32,658,693

99.9%

4,000

0.01%

Resolution 6: To grant the directors authority to allot shares pursuant to Section 551 of the Companies Act 2006.

32,658,693

99.9%

4,000

0.01%

Resolution 7*: To dis-apply pre-emption rights pursuant to Section 570 of the Companies Act 2006.

32,658,693

99.9%

4,000

0.01%

Resolution 8*: To authorise the directors to make market purchases.

32,662,693

100.0%

0

0.00%

*Special resolutions

For further information, please visit www.belluscura.com or contact:  

Belluscura plc

www.belluscura.com

Robert Rauker, Chief Executive Officer

via Walbrook PR

Anthony Dyer, Chief Financial Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Dowgate Capital Limited (Broker)

Tel: +44 (0)20 3903 7715

James Serjeant / Nicholas Chambers

Walbrook PR Ltd (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com

Paul McManus / Sam Allen

Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDZGZDMKKGZZM
Date   Source Headline
25th Oct 20217:00 amRNSProduct wins Top Award at US Trade show
18th Oct 20217:00 amRNSNew US Distribution Agreement
8th Oct 20217:00 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Results
31st Aug 20217:00 amRNSBelluscura supports rationale for wider oxygen use
27th Jul 20217:00 amRNSManufacturing and Distribution Agreement
13th Jul 20217:00 amRNSThird US Distribution Agreement
8th Jul 20217:00 amRNSThe US Centers for Medicare & Medicaid Services
5th Jul 20217:00 amRNSSecond US Distribution Agreement
30th Jun 202112:29 pmRNSResult of AGM
24th Jun 20211:13 pmRNSHolding(s) in Company
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20212:05 pmRNSSecond Price Monitoring Extn
23rd Jun 20212:00 pmRNSPrice Monitoring Extension
23rd Jun 20217:00 amRNSFirst US Distribution Agreement
15th Jun 20217:00 amRNSSenior Management Appointment
9th Jun 20214:15 pmRNSExercise of Warrants
2nd Jun 20217:00 amRNSHolding(s) in Company
28th May 20217:00 amRNSAdmission to trading on AIM; First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.